MSB 7.69% $1.19 mesoblast limited

2023 The Final Countdown, page-786

  1. 5,630 Posts.
    lightbulb Created with Sketch. 2033
    Glofitamab already approved. Only 5 ahead of us!

    https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-glofitamab-gxbm-selected-relapsed-or-refractory-large-b-cell
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.